相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Oestrogen receptor positive breast cancer metastasis to bone: inhibition by targeting the bone microenvironment in vivo
I. Holen et al.
CLINICAL & EXPERIMENTAL METASTASIS (2016)
Estrogen anti-inflammatory activity on human monocytes is mediated through cross-talk between estrogen receptor ERα36 and GPR30/GPER1
Vasiliki Pelekanou et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Periostin promotes immunosuppressive premetastatic niche formation to facilitate breast tumour metastasis
Zhe Wang et al.
JOURNAL OF PATHOLOGY (2016)
CAPG and GIPC1: Breast Cancer Biomarkers for Bone Metastasis Development and Treatment
Jules A. Westbrook et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Metastatic colonization by circulating tumour cells
Joan Massague et al.
NATURE (2016)
Delineating the effects of 5-fluorouracil and follicle-stimulating hormone on mouse bone marrow stem/progenitor cells
Ambreen Shaikh et al.
STEM CELL RESEARCH & THERAPY (2016)
CAPG and GIPC1: Breast Cancer Biomarkers for Bone Metastasis Development and Treatment
Jules A. Westbrook et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
The Osteogenic Niche Promotes Early-Stage Bone Colonization of Disseminated Breast Cancer Cells
Hai Wang et al.
CANCER CELL (2015)
Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy
Russell Hughes et al.
CANCER RESEARCH (2015)
OPG-Fc inhibits ovariectomy-induced growth of disseminated breast cancer cells in bone
Penelope D. Ottewell et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Transcriptional regulation of tenascin-W by TGF-beta signaling in the bone metastatic niche of breast cancer cells
Francesca Chiovaro et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial
Michael Gnant et al.
LANCET (2015)
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials
R. Coleman et al.
LANCET (2015)
The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase
Thomas R. Cox et al.
NATURE (2015)
Estrogenic gper signaling regulates mir144 expression in cancer cells and cancer-associated fibroblasts (cafs)
Adele Vivacqua et al.
ONCOTARGET (2015)
Incidence of bone metastases and survival after a diagnosis of bone metastases in breast cancer patients
M. Harries et al.
CANCER EPIDEMIOLOGY (2014)
Zoledronic Acid Has Differential Antitumor Activity in the Pre- and Postmenopausal Bone Microenvironment In Vivo
Penelope D. Ottewell et al.
CLINICAL CANCER RESEARCH (2014)
Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results
R. Coleman et al.
ANNALS OF ONCOLOGY (2013)
Expression of follicle-stimulating hormone receptor by the vascular endothelium in tumor metastases
Ahsan Siraj et al.
BMC CANCER (2013)
Tumor Cell Dissemination: Emerging Biological Insights from Animal Models and Cancer Patients
Yibin Kang et al.
CANCER CELL (2013)
Parathyroid Hormone-Related Protein Drives a CD11b+Gr1+ Cell-Mediated Positive Feedback Loop to Support Prostate Cancer Growth
Serk In Park et al.
CANCER RESEARCH (2013)
The perivascular niche regulates breast tumour dormancy
Cyrus M. Ghajar et al.
NATURE CELL BIOLOGY (2013)
Stromal Estrogen Receptor-α Promotes Tumor Growth by Normalizing an Increased Angiogenesis
Christel Pequeux et al.
CANCER RESEARCH (2012)
Seed, soil and secreted hormones: Potential interactions of breast cancer cells with their endocrine/paracrine microenvironment and implications for treatment with bisphosphonates
C. Wilson et al.
CANCER TREATMENT REVIEWS (2012)
Location matters: osteoblast and osteoclast distribution is modified by the presence and proximity to breast cancer cells in vivo
H. K. Brown et al.
CLINICAL & EXPERIMENTAL METASTASIS (2012)
When versatility matters: activins/inhibins as key regulators of immunity
G. R. Aleman-Muench et al.
IMMUNOLOGY AND CELL BIOLOGY (2012)
Oestrogen-deficiency inducing haematopoiesis dysfunction via reduction in haematopoietic stem cells and haematopoietic growth factors in rats
Xi Qiu et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2012)
Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial
Alexander H. G. Paterson et al.
LANCET ONCOLOGY (2012)
A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells
Kim J. Png et al.
NATURE (2012)
Blocking antibody to the β-subunit of FSH prevents bone loss by inhibiting bone resorption and stimulating bone synthesis
Ling-Ling Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy
Christelle P. El-Haibi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Variation of female prolactin levels with menopausal status and phase of menstrual cycle
Melissa J. Tanner et al.
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY (2011)
Gap Junction-Mediated Import of MicroRNA from Bone Marrow Stromal Cells Can Elicit Cell Cycle Quiescence in Breast Cancer Cells
Philip K. Lim et al.
CANCER RESEARCH (2011)
Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow
Yusuke Shiozawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Osteoclasts are dispensable for hematopoietic stem cell maintenance and mobilization
Kana Miyamoto et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial
Michael Gnant et al.
LANCET ONCOLOGY (2011)
Breast-Cancer Adjuvant Therapy with Zoledronic Acid
Robert E. Coleman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Follicle-stimulating hormone, interleukin-1, and bone density in adult women
Joseph G. Cannon et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2010)
Effects of Suppression of Follicle-Stimulating Hormone Secretion on Bone Resorption Markers in Postmenopausal Women
Matthew T. Drake et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Metastasis: from dissemination to organ-specific colonization
Don X. Nguyen et al.
NATURE REVIEWS CANCER (2009)
Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor κB ligand/osteoprotegerin ratio
Dutmanee Seriwatanachai et al.
BONE (2008)
Metastatic breast cancer induces an osteoblast inflammatory response
Michelle Kinder et al.
EXPERIMENTAL CELL RESEARCH (2008)
A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project
H. G. Burger et al.
HUMAN REPRODUCTION UPDATE (2007)
Genes associated with breast cancer metastatic to bone
Marcel Smid et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Bone turnover across the menopause transition: Correlations with inhibins and follicle-stimulating hormone
DS Perrien et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Osteoprotegerin (OPG) - a potential new role in the regulation of endothelial cell phenotype and tumour angiogenesis?
SS Cross et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]
T Powles et al.
BREAST CANCER RESEARCH (2006)
A pooled analysis of bone marrow micrometastasis in breast cancer
S Braun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Osteoprotegerin (OPG) expression by breast cancer cells in vitro and breast tumours in vivo -: a role in tumour cell survival?
I Holen et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion
A Orimo et al.
CELL (2005)
Age-related analysis of inhibin A, inhibin B, and activin a relative to the intercycle monotropic follicle-stimulating hormone rise in normal ovulatory women
NA Klein et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Localization of activin and inhibin subunits, receptors and SMADs in the mouse mammary gland
JS Jeruss et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2003)
The skeleton as a unique environment for breast cancer cells
AM Mastro et al.
CLINICAL & EXPERIMENTAL METASTASIS (2003)
Molecular pathways in bone marrow homing:: dominant role of α4β1 over β2-integrins and selectins
T Papayannopoulou et al.
BLOOD (2001)
Biology of osteoclast activation in cancer
GD Roodman
JOURNAL OF CLINICAL ONCOLOGY (2001)
Involvement of chemokine receptors in breast cancer metastasis
A Müller et al.
NATURE (2001)
TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand
J Lam et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Identifying breast cancer patients at high risk for bone metastases
M Colleoni et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)